230 related articles for article (PubMed ID: 28399096)
41. [Polyneuropathy--therapy].
Meyer FP
Dtsch Med Wochenschr; 2003 Mar; 128(11):572; author reply 572. PubMed ID: 12635035
[No Abstract] [Full Text] [Related]
42. The role of lipoic acid in the treatment of diabetic polyneuropathy.
Biewenga G; Haenen GR; Bast A
Drug Metab Rev; 1997 Nov; 29(4):1025-54. PubMed ID: 9421684
[No Abstract] [Full Text] [Related]
43. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs].
Bregovskiĭ VB; Posokhina OV; Karpova IA
Ter Arkh; 2005; 77(10):15-9. PubMed ID: 16320678
[TBL] [Abstract][Full Text] [Related]
44. [Drug treatment of diabetic polyneuropathy with alpha-lipoic acid or vitamin B preparations. A clinical and neurophysiologic study].
Jörg J; Metz F; Scharafinski H
Nervenarzt; 1988 Jan; 59(1):36-44. PubMed ID: 2832774
[No Abstract] [Full Text] [Related]
45. Potential for Novel Therapeutic Uses of Alpha Lipoic Acid.
Fasipe B; Faria A; Laher I
Curr Med Chem; 2023; 30(35):3942-3954. PubMed ID: 36201272
[TBL] [Abstract][Full Text] [Related]
46. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
47. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Jin HY; Joung SJ; Park JH; Baek HS; Park TS
Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
[TBL] [Abstract][Full Text] [Related]
48. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
49. Treatment for diabetic mononeuropathy with alpha-lipoic acid.
Tankova T; Cherninkova S; Koev D
Int J Clin Pract; 2005 Jun; 59(6):645-50. PubMed ID: 15924591
[TBL] [Abstract][Full Text] [Related]
50. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
51. Thioctic acid-induced acute cholestatic hepatitis.
Ridruejo E; Castiglioni T; Silva MO
Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
[TBL] [Abstract][Full Text] [Related]
52. (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy.
Brufani M; Figliola R
Acta Biomed; 2014 Aug; 85(2):108-15. PubMed ID: 25245645
[TBL] [Abstract][Full Text] [Related]
53. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review.
Hsieh RY; Huang IC; Chen C; Sung JY
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630823
[TBL] [Abstract][Full Text] [Related]
54. [Lipoic acid: physiological role and prospects for clinical application].
Tutelyan VA; Makhova AA; Pogozheva AV; Shikh EV; Elizarova EV; Khotimchenko SA
Vopr Pitan; 2019; 88(4):6-11. PubMed ID: 31722135
[TBL] [Abstract][Full Text] [Related]
55. Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.
Ibrahimpasic K
Med Arch; 2013; 67(1):7-9. PubMed ID: 23678828
[TBL] [Abstract][Full Text] [Related]
56. [Diabetic encephalopathy: current insights and potential therapeutic strategies].
Esin RG; Khairullin IK; Esin OR
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):49-54. PubMed ID: 34460157
[TBL] [Abstract][Full Text] [Related]
57. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
[TBL] [Abstract][Full Text] [Related]
58. [Thioctic (alpha-lipoic) acid-spectrum of clinical use].
Vorob'eva OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):86-90. PubMed ID: 22500323
[No Abstract] [Full Text] [Related]
59. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
Wang XT; Lin HX; Xu SA; Lu YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
[TBL] [Abstract][Full Text] [Related]
60. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
